Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fatty acid β-oxidation pathway is a central metabolic process that catabolizes fatty acids into acetyl-CoA, NADH, and FADH₂. This process occurs primarily in the mitochondria and provides a major source of ATP, especially in tissues like heart and skeletal muscle. The pathway consists of four recurring enzymatic steps: dehydrogenation, hydration, second dehydrogenation, and thiolytic cleavage. Long-chain fatty acids require activation and transport into the mitochondria via the carnitine shuttle. The pathway is tightly regulated at multiple levels, including entry into the cell and mitochondrial entry. Defects in enzymes involved can lead to metabolic disorders like MCADD. Drugs that target FAO primarily modulate fatty acid transport into mitochondria. Complete oxidation of palmitate yields ~129 ATP.
Inhibition of fatty acid transport into mitochondria (e.g., CPT1 inhibition), modulation of enzyme activity within the pathway.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty Acid β-Oxidation Pathway (FAO).